Clinical dose findings of sitafloxacin treatment: pharmacokinetic–pharmacodynamic analysis of two clinical trial results for community-acquired respiratory tract infections

2013 ◽  
Vol 19 (3) ◽  
pp. 486-494 ◽  
Author(s):  
Shigeru Kohno ◽  
Katsunori Yanagihara ◽  
Yoshihito Niki ◽  
Jun-ichi Kadota ◽  
Mitsuo Kaku ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Clinical Dose ◽  
Pharmacodynamic Analysis ◽  
Clinical Trial Results ◽  
Tract Infections

Homeopathic medicines for prevention of influenza and acute respiratory tract infections in children: blind, randomized, placebo-controlled clinical trial

Homeopathy ◽  
2016 ◽  
Vol 105 (1) ◽  
pp. 71-77 ◽  
Author(s):  
Camila Monteiro Siqueira ◽  
Fortune Homsani ◽  
Venício Féo da Veiga ◽  
Carlos Lyrio ◽  
Haroldo Mattos ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Controlled Clinical Trial ◽  
Acute Respiratory Tract Infections ◽  
Tract Infections

Prospective Clinical Trial on the Efficacy of Amoxycillin Administered Twice or Four Times Daily in Children with Respiratory Tract Infections

1981 ◽  
Vol 9 (4) ◽  
pp. 274-276 ◽  
Author(s):  
F D Daschner ◽  
U Behre ◽  
A Dalhoff
Keyword(s):  
Clinical Trial ◽  
Body Weight ◽  
Respiratory Tract ◽  
Lower Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Lower Respiratory Tract Infections ◽  
Duration Of Therapy ◽  
Daily Dose ◽  
Tract Infections ◽  
To Receive

Thirty-four children with upper or lower respiratory tract infections were randomly allocated to receive either a twice daily or four times daily dose of 50 mg amoxycillin/kg body-weight/day. Mean duration of therapy was identical in both groups. Peak and trough antibiotic concentrations were determined. Eradication of bacteria, clinical improvement and side-effects were comparable in both groups.

Sign in / Sign up

Export Citation Format

Share Document